Multimodal healthcare provider Carbon Health is stepping into chronic condition management with its recent acquisition of Steady Health, an integrated diabetes care platform. The terms of the deal were not disclosed.
The acquisition will support Carbon Health’s primary care model, which combines in-person clinics with a virtual care platform. Carbon Health patients can receive services ranging...
Fitterfly, an India-based digital therapeutics company, has launched a digital recovery programme for diabetic patients who have contracted COVID-19.
WHAT IT DOES
The company has added in its Diabefly platform an integrated module called the Post COVID-19 Recovery programme. According to a press release, people can "take advantage of the programme from the comfort of their home via calls, chat,...
Gamification has become an increasingly popular strategy for promoting healthy behaviors from medication adherence to chronic condition management.
A new study published in JAMA Network examined the effectiveness of gamification in promoting physical activity and weight loss among adults with uncontrolled Type 2 diabetes.
"Gamification is commonly used in wellness programs and smartphone apps,...
Chinese medical device innovation hub Dinova Medtech and US-based medical device company Metronom Health have established a joint venture to develop and sell a continuous glucose monitoring system in China.
WHY IT MATTERS
Traditional fingerstick glucose meters can only provide information about intermittent glucose levels and the pain that comes with finger pricking can potentially reduce...
This morning, Bigfoot Biomedical announced it has received FDA 510(k) clearance for its Bigfoot Unity Diabetes Management System.
The system was cleared for use among individuals 12 years old and up with Type 1 or Type 2 diabetes who use multiple-dose injection therapy.
Included in the Bigfoot Unity System are two smartpen caps for both rapid- and long-acting insulin, a connected mobile app, an...
Pharma giant Eli Lilly has inked a series of deals with four diabetes management companies to integrate with its forthcoming Tempo Pen and Tempo Smart Button products.
The companies that signed strategic international agreements with Eli Lilly are Dexcom, Glooko, myDiabby Healthcare and Roche.
Through the agreements, Eli Lilly’s Tempo Pen and connected Tempo Smart Button will integrate with the...
A Dubai-based specialist diabetes clinic has released its very first report on the outcomes of its care model, demonstrating that continuous data monitoring is advantageous in dramatically improving the health of those with the condition.
GluCare Integrated Diabetes Center, which describes itself as the “world’s first healthcare provider to employ integrated continuous data monitoring” and the “...
South Korean fabless manufacturer Dongwoon Anatech is seeking the approval of both the US and Korean Food and Drug Administration for the commercial rollout of its saliva-based glucose monitoring device after completing its first clinical trial in December.
WHAT IT DOES
The glucose monitoring device called D-SaLife, a product of six years of research and development, makes use of microcurrent...
Glooko, the maker of a digital platform for managing diabetes and other chronic diseases, announced today a $30 million Series D funding round led by Health Catalyst Capital. Canaan Partners, Georgian, Novo Nordisk, Insulet and Mayo Clinic also played a part in the raise.
WHAT IT DOES
The Palo Alto startup's app-based platform acts as a central hub for connected monitoring devices and other...
DarioHealth announced today that it is expanding its digital chronic-disease-management business beyond diabetes and hypertension with the purchase of Upright Technologies, a musculoskeletal (MSK) health company that specializes in connected posture correction devices and digital coaching.
The deal is expected to close on or around February 7, and will run DarioHealth $31 million to complete the...